Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AccuVein
AddedFeb 15, 2024
UpdatedJun 18, 2026
AccuVein

AccuVein

Series B

AccuVein designs innovative solutions for enhanced peripheral vasculature visualization.

HQ
Medford, NY, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to enhance healthcare practices, AccuVein focuses on developing innovative solutions for the visualization of peripheral vasculature. Their core product, the Vein Visualization System, aids medical professionals in locating veins more accurately, thereby improving patient care and reducing the need for multiple needle sticks. AccuVein serves a diverse market including acute care, aesthetics, and non-acute care settings, aiming to improve the overall patient experience and healthcare equity.

AccuVein has garnered attention from notable investors and healthcare professionals who recognize the impact of their technology. The company has achieved significant milestones, including widespread adoption in hospitals and clinics globally. By improving the accuracy of vein detection, AccuVein has not only enhanced patient comfort but also increased the efficiency of medical procedures, solidifying its role as a transformative player in the healthcare industry.

AccuVein - Similar Companies

NextVein logo

NextVein

nextvein.com

VascuLogic logo

VascuLogic

Access Vascular logo

Access Vascular

InnoVein logo

InnoVein

Vena Medical logo

Vena Medical

venamed.ca

Evena Medical logo

Evena Medical

evenamed.com

IntraVu logo

IntraVu

intravu.com

AngioDynamics logo

AngioDynamics

angiodynamics.com

Bluegrass Vascular Technologies logo

Bluegrass Vascular Technologies

Accumed Systems logo

Accumed Systems

Vasc-Alert logo

Vasc-Alert

vasc-alert.com

ivWatch logo

ivWatch

ivwatch.com

Versago Vascular Access logo

Versago Vascular Access

I-V Access Technology logo

I-V Access Technology

ivatinc.com

Inari Medical logo

Inari Medical

inarimedical.com

AccuVein - Quick Facts

Who are AccuVein's competitors?

Companies similar to AccuVein include NextVein, VascuLogic, Access Vascular and InnoVein.

When was AccuVein founded?

AccuVein was founded in 2006.

Where is AccuVein's headquarters located?

AccuVein's headquarters is located in Medford, NY, US.

When was AccuVein's last funding round?

AccuVein's most recent funding round was for $17.3M (USD) in September 2020.

How much has AccuVein raised to-date?

As of Sep 8, 2020, AccuVein has raised a total of $69.3M (USD).

How many employees does AccuVein have?

AccuVein has 110 employees as of Feb 5, 2024.

AccuVein - Classification

Industry
  • Hardware
Technology
  • Imaging
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified